IFR Puts 2025 Humanoid Sales at 7,000; China Holds 90% of Quadrupeds
The International Federation of Robotics puts global humanoid robot sales at roughly 7,000 units in 2025, confined to industrial and professional service applications. It is the first authoritative baseline for a category routinely described in larger numbers. Counterpoint Research data show quadruped shipments near 35,000 units in the first half of 2026, with China above 90% share and Unitree at 37%.
Deployment milestones centered on integration rather than prototypes. Boston Dynamics opened a Robotics Metaplant Application Center inside Hyundai's Georgia plant, training Atlas on real automotive parts via teleoperation and simulation. UBTECH Robotics shipped the first batch of its UWORLD U1 bionic humanoid line, and Agility's Digit 5 is designed around swappable grippers so one unit covers multiple tasks. End-effector interchangeability addresses the utilization constraint governing deployment payback.
Component economics moved as well. Unitree released the Dex5-S, a 22-degrees-of-freedom dexterous hand in a 1:1 human-hand form factor from $6,500, with all joints backdrivable. Figure AI reported 56% success on household tasks across 30 real homes under Helix 2.5 and framed the data as evidence of a human-to-robot scaling law; peers dispute that reading, citing limited generalization in imitation learning.
Capital and policy moved against the shipment data. Chinese regulators gave investment banks informal guidance to raise IPO review standards for humanoid robot companies, with emphasis on revenue authenticity. Paixini filed for A-share IPO counseling after raising over 4 billion yuan at a valuation above 10 billion, indicating how tactile-sensor suppliers approach public markets. Analyst work positions warehouses as the first substantial test of embodied AI in China, where system-level integration outweighs single-robot performance.
Two observation points follow. The distance between the 7,000-unit baseline and announced deployment pipelines will be settled by audited 2026 shipments. Tighter listing scrutiny should redirect capital toward verifiable revenue, favoring component suppliers and integrators over pre-commercial humanoid developers.